OLIVIA QUIDO BLEMISH ERASER

HYDROQUINONE TOPICAL HUMAN PRESCRIPTION DRUG

OLIVIA QUIDO BLEMISH ERASER is an FDA drug label for the active ingredient HYDROQUINONE manufactured by O Skin Care LLC administered by TOPICAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20220605.

Generic name
HYDROQUINONE
Manufacturer
O Skin Care LLC
Product type
HUMAN PRESCRIPTION DRUG
Route
TOPICAL
Dosage form
N/A
NDC
71421-801
Application
N/A
Label effective
20220605

Indications & Usage

INDICATIONS AND USAGE 1.1Indication BLEMISH ERASER is a combination of hydrocortisone (a corticosteroid), hydroquinone (a melanin synthesis inhibitor), and a tretinoin (a retinoid) that is indicated for the gradual bleaching of hyperpigmented skin conditions age and liver spots, freckles, and other unwanted areas of melanin hyperpigmentation, in the presence of measures for sun avoidance, including the use of sunscreen. 1.2 Limitations of Use The safety and efficacy of BLEMISH ERASER in pregnant women and nursing mothers have not been established. BLEMISH ERASER is a hydroquinone (a melanin synthesis inhibitor) that is indicated for the gradual bleaching of hyperpigmented skin conditions age and liver spots, freckles, and other unwanted areas of melanin hyperpigmentation, in the presence of measures for sun avoidance, including the use of sunscreen. (1)

Dosage & Administration

2 DOSAGE AND ADMINISTRATION Gently wash the face and neck with a mild cleanser. Rinse and pat the skin dry. Apply a thin film of BLEMISH ERASER to the affected area once daily at night or as directed by a doctor. During the day, use O Skin Sunscreen SPF-50, and wear protective clothing. Avoid sunlight exposure to prevent repigmentation. BLEMISH ERASER is for topical use only. It is not for oral, ophthalmic, or intravaginal use. 2 DOSAGE AND ADMINISTRATION Gently wash the face and neck with a mild cleanser. Rinse and pat the skin dry. Apply a thin film of BLEMISH ERASER to the affected area once daily at night or as directed by a doctor. During the day, use O Skin Sunscreen SPF-50, and wear protective clothing. Avoid sunlight exposure to prevent repigmentation. BLEMISH ERASER is for topical use only. It is not for oral, ophthalmic, or intravaginal use.

Contraindications

BLEMISH ERASER is contraindicated in individuals with a history of hypersensitivity to this product or any of its components.. (4) BLEMISH ERASER is contraindicated in individuals with a history of hypersensitivity to this product or any of its components.. (4)

Warnings

Not available.

Adverse Reactions

No systemic adverse reactions have been reported. Occasional hypersensitivity (localized contact dermatitis) may occur, in which case the medication should be discontinued and the physician notified immediately. In case of adverse reaction, call a doctor. (6) To report SUSPECTED ADVERSE REACTIONS, contact FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

More products with the same ingredient

HYDROQUINONE

Hydro-Q

Dermavance Pharmaceuticals View label

Hydroquinone

Westminster Pharmaceuticals, LLC View label

Hydroquinone 4%

SOHM, Inc. View label

Hydroquinone cream

APNAR PHARMA LP View label

OBAGI-C Rx system C-CLARIFYING SERUM NORMAL TO oily SKIN LIGHTENING SERUM WITH VITAMIN C

Obagi Cosmeceuticals LLC View label

Obagi-C Rx system C-Therapy Night Skin Lightening with Vitamins C and E

Obagi Cosmeceuticals LLC View label